메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

전체기사

All-in-One Excellence: Huion Kamvas Pro 24 (Gen 3) - The Ultimate Drawing Display for Creatives

LOS ANGELES, Oct. 22, 2025 -- Huion officially releases the highly anticipated Kamvas Pro 24 (Gen 3) drawing display. This new model is designed for professional art communities, particularly those seeking a large-sized pen display with cutting-edge features, a natural pen experience, and sharp display quality. As Huion continues with its strategy of continuous development and responds to the rapid advancements in digital painting, design, and media industries, the iteration and upgrade of the previous Kamvas Pro 24 (4K) is imminent. Kamvas Pro 24 (Gen 3) brings
- 김장윤(JASON KIM) 기자
- 2025-10-22 15:00
LISCure BioSciences Secures World's First Approval for "Joint Health Probiotic" as Recognized Health Functional Ingredient

SEOUL, South Korea, Oct. 22, 2025 -- LISCure BioSciences ("LISCure") announced that its proprietary joint health probiotic, JointWorks®, has been officially approved by the Korean Ministry of Food and Drug Safety (MFDS) as Recognized Health Functional Ingredient. This approval marks a historic milestone — JointWorks® is the world's first probiotic clinically proven to support joint health and remains the only probiotic ingredient approved by the MFDS for joint functionality. Breakthrough in Joint Health Innovation Developed exclusively by LISCure, Joint
- 김갑성 기자
- 2025-10-22 14:28
Renalys Pharma Announces Support for Alport Syndrome Registry Study Organized by Japanese Society for Pediatric Nephrology

TOKYO, Oct. 22, 2025 -- Renalys Pharma, Inc. (Headquarters: Chuo-ku, Tokyo; "Renalys") is pleased to announce the company is providing financial support for the Alport Syndrome Registry Study organized by the Japanese Society for Pediatric Nephrology (Head Office: Chiyoda-ku, Tokyo). The study is headed by Professor Kandai Nozu, Department of Pediatrics, Graduate School of Medicine, Kobe University. Renalys will provide research funding for this initiative but will not be involved in the study's undertaking, data analysis, or publication. Speaking on the announcement, Profess
- 김갑성 기자
- 2025-10-22 14:00
ACM Biolabs Reports Favorable Safety Signals and Early Pharmacodynamics from Intramuscular Administration of ACM-CpG in Patients with Advanced Solid Tumors

SINGAPORE, Oct. 22, 2025 -- ACM Biolabs, a clinical-stage biotechnology company developing next-generation nanoparticle-based immunotherapies, today announced encouraging early clinical findings from its ongoing Phase 1 study of ACM-CpG, a TLR9 agonist formulated with ACM's proprietary polymersome platform through a strategic collaboration with the National Cancer Centre Singapore (NCCS). Preclinical experiments show that the ACM nanoparticle formulation fundamentally alters CpG's mechanism of action, enabling myeloid modulation through comprehensive TLR9 engagement in immunologically
- 김갑성 기자
- 2025-10-22 14:00
ACM 바이오랩스, 진행성 고형암 환자 대상 ACM-CpG 근육 내 투여에서 양호한 안전성 실마리정보 및 초기 약력학 결과 보고

[ 메디채널 김갑성 기자 ] 싱가포르 2025년 10월 22일 -- 차세대 나노입자 기반 면역치료제를 개발 중인 임상단계 바이오테크 기업 ACM 바이오랩스(ACM Biolabs)가 싱가포르 국립암센터(NCCS)와의 전략적 협력을 통해 ACM의 독자적 폴리머솜(polymersome) 플랫폼으로 제형화된 TLR9 작용제 ACM-CpG를 대상으로 진행 중인 1상 임상시험에서 얻은 고무적인 초기 임상 결과를 발표했다. 전임상 실험 결과, ACM 나노입자 제형은 CpG의 작용기전을 근본적으로 변화시켜 면역학적으로 '차가운' 종양에서 TLR9의 포괄적 관여를 통한 골수 조절을 가능케 하는 것으로 나타났다. 진행 중인 1상 임상시험(NCT06587295)[i]은 현재 싱가포르 국립암센터에서 ACM-CpG의 안전성, 내약성 및 약력학적 효과를 평가하기 위해 진행성 고형암 환자를 등록 중이다. 초기 임상 데이터는 이러한 전임상 결과가 인간에게도 적용되고 있음을 보여준다. 진행성 고형암 환자에게 ACM-CpG를 근육 내 투여(CpG 0.25mg의 저용량으로 주 1회 또는 격주 투여)한 결과, 생체표지자 데이터를 통해 강력한 전신 면역 활성화 효과
- 김갑성 기자
- 2025-10-22 14:00
Ubisoft Singapore Elevates Game Audio with Neumann Studio Monitors

[ 메디채널 김장윤(JASON KIM) 기자 ] Studio Blue sets new benchmarks for game audio production SINGAPORE, Oct. 22, 2025 -- Ubisoft Singapore, a leading AAA game development studio in Southeast Asia, has recently outfitted its newly upgraded Studio Blue with Neumann studio monitors which belongs to Sennheiser Group to support advanced audio production workflows. As the first Dolby Atmos-enabled game development sound studio in Southeast Asia, Studio Blue is fitted with eleven Neumann KH 80 DSPs and a KH 810 subwoofer, delivering precision and clarity for immersive sound design.
- 김장윤(JASON KIM) 기자
- 2025-10-22 13:00
Taiwan Launches Asia Innovation Capital Initiative to Become AI Hub

TAIPEI, Oct. 22, 2025 -- The Financial Supervisory Commission (FSC), in collaboration with the Taiwan Stock Exchange (TWSE) and Taipei Exchange (TPEx), has launched the Asia Innovation Capital initiative, a strategic program led by the FSC to strengthen Taiwan's capital markets and establish the market as a regional hub for innovation and artificial intelligence. "This initiative is instrumental in driving long-term industrial development and strengthening the global competitiveness of our capital markets," said FSC Chairman Peng Jin-lung. He emphasized that the platform offe
- 황정호 기자
- 2025-10-22 12:10
Citibank is Ranked No. 1 Among Banks in Singapore for Total Experience in Report by Independent Research Firm

Bank takes top spot in inaugural report combining brand and customer experience SINGAPORE, Oct. 22, 2025 -- Citibank was ranked first out of six banks in the inaugural Singapore total customer experience score rankings, 2025 report by global research and advisory firm Forrester. The Total Experience Score is a composite of Forrester's Brand Experience (BX) Index and Customer Experience (CX) Index scores that measure the perceptions that both noncustomers and customers form based on their cumulative interactions with a brand. Yeo Wenxian, Citibank Si
- 황정호 기자
- 2025-10-22 11:40
Bank Indonesia Successfully Hosts the Peak Event of IN2MOTIONFEST 2025, Showcasing 1,785 Modest Fashion Works Highlighting the Richness of Indonesian Wastra (Traditional Textiles)

JAKARTA, Indonesia, Oct. 22, 2025 -- Teaming up with the Indonesian Fashion Chamber (IFC), Bank Indonesia successfully held the peak event of the Indonesia International Modest Fashion Festival (IN2MOTIONFEST) 2025 from October 8–12, 2025, at the JIEXPO Convention Centre & Theater, Jakarta, as part of the Indonesia Sharia Economic Festival (ISEF) 2025. ISEF is Indonesia's largest annual sharia economic and financial event, serving as a platform that integrates various activities in the Islamic economic and financial (sharia economy) sector. IN2MOTIONFEST 2025, officially op
- 황정호 기자
- 2025-10-22 11:27
NETMARBLE'S BRUTAL DARK FANTASY MMORPG "RAVEN2" LAUNCHES WORLDWIDE

[ 메디채널 김장윤(JASON KIM) 기자 ] Available Now on Mobile and PC across 150 Countries; Special In-Game Launch Events Are Now Live SEOUL, South Korea, Oct. 22, 2025 -- Netmarble, a renowned developer and publisher of high-quality games, officially announced the grand launch of its brutal dark fantasy MMORPG Raven2, now available worldwide on both mobile and PC. The launch spans 150 countries across North America, Southeast Asia & Oceania, and Europe, and is available in 16 languages. Players can download the game here. Powered by Unreal Engine, Raven2 showcases unrivaled
- 김장윤(JASON KIM) 기자
- 2025-10-22 11:00

이전

21 22 23 24 25 26 27 28 29 30

많이 본 기사

최근기사

2025-10-29_WED

2025-10-28_TUE

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2025년 10월 29일 02시 40분